BIBFRAME Work
Title
Nanomedicine for neurodegenerative disorders
Type
- Text
- Monograph
Contribution
Subject
- Nanoparticles--therapeutic use (MESH)
- Blood-Brain Barrier--metabolism (MESH)
- Nanoparticle Drug Delivery System--therapeutic use (MESH)
- Neurodegenerative Diseases--drug therapy (MESH)
Language
Classification
- DDC: 616.8/3 (Assigner: dlc)
- LCC: RC376.5 (Assigner: dlc) (Status: used by assigner)
- NLM: WL 358.5 (Assigner: dnlm) (Status: used by assigner)
Content
Supplementary content
Summary
"With the population getting older and with a corresponding increase in neurodegenerative diseases (NDs) worldwide, developing drug delivery systems that can overcome conventional barriers in treating these diseases is the need of the hour. Drug delivery by nanotechnology has great promise for detecting and treating a wide range of neurodegenerative conditions. This new book provides an informative overview of the cutting-edge applications of various nanocarriers that encapsulate active compounds to effectively treat NDs. Providing a comprehensive review of neurological disorders, clinical strategies for the management of neuro disorders, and the challenges in their treatment, the book first reviews the types, diagnosis, and treatment strategies, including biomarkers in detection, diagnosis, and prognosis of neurodegenerative disorders. It then provides an overview of the blood-brain barrier (BBB) transport mechanisms. It discusses specific techniques such as the delivery of RNA/DNA to the brain using nanoscience, nanodiamonds as emerging nanotherapeutics for brain-targeted drug delivery, the use of herbal nano-formulations, and more. Clinical researchers and other scientists working to reduce the obstacles to delivering drugs and genes in a more efficient and targeted manner for the treatment of neurodegenerative diseases will find Nanomedical Drug Delivery for Neurodegenerative Diseases to be an invaluable resource"-- Provided by publisher.
Table of Contents
Neurodegenerative disorders : concept, types, and treatment strategies / Chandana Majee, Rupa Mazumder, and Bhawani Pantela -- Overview of the blood-brain barrier (BBB) transport mechanisms / Shilpa Verma, Mahesh Gaikwad, Gajanan Paul, and A. K. Yadav -- Nanodiamonds as emerging nanotherapeutics for brain-targeted drug delivery in the management and diagnosis of neurodegenerative disorders / Bhagawati Saxena, Fagun Pathak, Bhavna Bohra, and Viral Shah -- The real issue in targeting neurodegenerative disease / Smriti Ojha, Anubhav Ananad, Hina Chadha, and Sudhanshu Mishra -- Strategies to cross the blood-brain barrier / Shraddha Dwivedi -- Nanotechnology-based drug delivery systems for the treatment of neurodegenerative disorders / Himanshu Paliwal, Bhupendra G. Prajapati, and Teerapol Srichana -- Nano approaches towards CNS drug delivery / Ashwani Sharma, Anjali Sharma, Girish Kumar, Tarun Virmani, and Kamla Pathak -- Current trends in drug-nano formulations directed to the brain / Dignesh Khunt, Brijesh Shah, Smit Nayi, Akshay Parihar, and Bhupendra Prajapati -- Selection of an appropriate technique for nano-carrier preparation : a multi-criteria decision-making methodology / Pankaj Sharma -- Delivery of RNA/DNA to the brain using nanoscience / Akanksha Sharma, Ashish Verma, Aditi Singh, and Rishabha Malviya -- Application of medicinal plants and their phytoconstituents used in the management of neurodegenerative diseases / Padmini Shukla and Prabodh Shukla -- Molecular mechanisms underpinning neuroprotection of nutritional polyphenols / Johnson O. Oladele, Isaac O. Babatunde, and Oluwaseun T. Oladele -- Implication of herbal nano-formulations in the treatment of neurological disorders / Sunny R. Shah, Vijay R. Chidrawar, Prashant L. Pingale, Sudarshan Singh, Bhupendra Prajapati, and Devang Sheth -- Medical laboratory diagnosis of neurodegenerative diseases toward adequate treatment in nanomedicine / Uchejeso Mark Obeta, Amaechi Eze Odono, Nkereuwem Sunday Etukudoh, and Obiora Reginald Ejinaka -- Role of biomarkers in detection, diagnosis, and prognosis of neurodegenerative disorders / Ruchi Singh, Ankita Moharana, Srishti Tiwari, Soubhik Bhattacharyya, Garima Tripathi, and Dhanalekshmi Unnikrishnan Meenakshi -- Use of nano-formulations in the treatment of neurodegenerative disorders / Ujjwal Gupta, Suryawanshi Ajay, Farhan Mazahir, and A. K. Yadav -- Nanostructured drug carriers for nose-to-brain drug delivery in the treatment of neurological disorders / Noopur Srivastava, Pawan Upadhyay, Alka Srivastava, Shibu Das, and Sudhanshu Mishra.
Authorized Access Point
Nanomedicine for neurodegenerative disorders
Admin Metadata
- Date: 2026-09-11T20:13:31.680279+00:00
- Agent: cbc
- Status: c
- Derived from: 23965166
Admin Metadata
- Date: 2026-09-11
- Cataloger id: Unknown
- Description level: http://id.loc.gov/ontologies/bibframe-2-6-0/
- Description language: eng
- Description authentication: pcc
Alternative Formats
Blue Core Actions
- Load to Marva Marva loads Instances, not Works. Open one of this Work's Instances and load that into Marva instead.
- Load to Sinopia
- Export to Catalog Only Instances can be exported. Open one of this Work's Instances and export that instead.